Jorge Villacian

1.2k total citations
21 papers, 800 citations indexed

About

Jorge Villacian is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Jorge Villacian has authored 21 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 12 papers in Virology and 9 papers in Epidemiology. Recurrent topics in Jorge Villacian's work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and Respiratory viral infections research (5 papers). Jorge Villacian is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and Respiratory viral infections research (5 papers). Jorge Villacian collaborates with scholars based in Singapore, United States and Spain. Jorge Villacian's co-authors include Arul Earnest, Li Yang Hsu, Nicholas I. Paton, P.L. Lim, Brenda Ang, Lawrence Lee, Justin A. Green, Carlos V. Payá, Yee‐Sin Leo and Vincent Soriano and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Jorge Villacian

19 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jorge Villacian Singapore	14	495	286	210	112	100	21	800
Dan Ouchi Spain	15	425 0.9×	342 1.2×	149 0.7×	156 1.4×	88 0.9×	50	781
Stefania Bellino Italy	18	477 1.0×	169 0.6×	359 1.7×	129 1.2×	75 0.8×	45	1.1k
Wasima Rida United States	16	408 0.8×	200 0.7×	341 1.6×	50 0.4×	46 0.5×	28	1.3k
Lewis McCurdy United States	16	456 0.9×	324 1.1×	465 2.2×	102 0.9×	20 0.2×	38	1.0k
Steffen Geis Germany	13	421 0.9×	227 0.8×	435 2.1×	202 1.8×	16 0.2×	27	864
Cynthia Wat United Kingdom	13	575 1.2×	429 1.5×	898 4.3×	99 0.9×	39 0.4×	34	1.4k
Tommy Rampling United Kingdom	11	230 0.5×	162 0.6×	185 0.9×	69 0.6×	50 0.5×	28	706
Henry Luzze Uganda	13	411 0.8×	106 0.4×	289 1.4×	81 0.7×	29 0.3×	29	630
Marie‐Luce Delforge Belgium	18	563 1.1×	155 0.5×	582 2.8×	49 0.4×	71 0.7×	48	999
Sirirat Likanonsakul Thailand	19	664 1.3×	312 1.1×	400 1.9×	68 0.6×	17 0.2×	41	889

Countries citing papers authored by Jorge Villacian

Since Specialization

Citations

This map shows the geographic impact of Jorge Villacian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Villacian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Villacian more than expected).

Fields of papers citing papers by Jorge Villacian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Villacian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Villacian. The network helps show where Jorge Villacian may publish in the future.

Co-authorship network of co-authors of Jorge Villacian

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Villacian. A scholar is included among the top collaborators of Jorge Villacian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Villacian. Jorge Villacian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Quer, Giorgio, Erin Coughlin, Jorge Villacian, et al.. (2024). Feasibility of wearable sensor signals and self-reported symptoms to prompt at-home testing for acute respiratory viruses in the USA (DETECT-AHEAD): a decentralised, randomised controlled trial. The Lancet Digital Health. 6(8). e546–e554. 5 indexed citations

Gentilotti, Elisa, Pasquale De Nardo, Eleonora Cremonini, et al.. (2021). Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis. Clinical Microbiology and Infection. 28(1). 13–22. 56 indexed citations

Gal, Micaela, Nick Francis, Kerenza Hood, et al.. (2018). Matching diagnostics development to clinical need: Target product profile development for a point of care test for community-acquired lower respiratory tract infection. PLoS ONE. 13(8). e0200531–e0200531. 13 indexed citations

Eede, Peter Van den, et al.. (2013). HIV-1 Genotyping of the Protease-Reverse Transcriptase and Integrase Genes to Detect Mutations That Confer Antiretroviral Resistance. Methods in molecular biology. 1030. 37–55. 5 indexed citations

Pattery, Theresa, et al.. (2012). Development and Performance of Conventional HIV-1 Phenotyping (Antivirogram®) and Genotype-Based Calculated Phenotyping Assay (virco®TYPE HIV-1) on Protease and Reverse Transcriptase Genes to Evaluate Drug Resistance. Intervirology. 55(2). 138–146. 18 indexed citations

Garrido, Carmen, Jorge Villacian, Natalia Zahonero, et al.. (2012). Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens. Antimicrobial Agents and Chemotherapy. 56(6). 2873–2878. 56 indexed citations

Rosa, Guy De La, Theresa Pattery, Gastón Picchio, et al.. (2010). Changing prevalence of darunavir resistance‐associated mutations (DRV RAMs) in clinical samples received for routine resistance testing: 2003‐2009. Journal of the International AIDS Society. 13(S4). 5 indexed citations

Pattery, Theresa, et al.. (2010). Effect of lipemia and bilirubinemia on HIV‐1 protease and reverse transcriptase genotyping and phenotyping success: a five‐year analysis. Journal of the International AIDS Society. 13(S4). 1 indexed citations

Craenenbroeck, Elke Van, et al.. (2009). Clinical cut-offs for HIV-1 phenotypic resistance estimates: Update based on recent pivotal clinical trial data and a revised approach to viral mixtures. Journal of Virological Methods. 162(1-2). 101–108. 16 indexed citations

10.

Poveda, Eva, Carmen de Mendoza, Theresa Pattery, et al.. (2008). Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues. AIDS. 22(17). 2395–2398. 32 indexed citations

11.

Mendoza, Carmen de, Kurt Van Baelen, Eva Poveda, et al.. (2008). Performance of a Population-Based HIV-1 Tropism Phenotypic Assay and Correlation With V3 Genotypic Prediction Tools in Recent HIV-1 Seroconverters. JAIDS Journal of Acquired Immune Deficiency Syndromes. 48(3). 241–244. 38 indexed citations

12.

Wilder‐Smith, Annelies, Hoe Nam Leong, & Jorge Villacian. (2006). In-flight transmission of Severe Acute Respiratory Syndrome (SARS): A Case Report. Journal of Travel Medicine. 10(5). 299–300. 28 indexed citations

13.

Cahn, Pedro, Jorge Villacian, Adriano Lazzarin, et al.. (2006). Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial. Clinical Infectious Diseases. 43(10). 1347–1356. 65 indexed citations

14.

Villacian, Jorge, et al.. (2005). The effect of infection with Mycobacterium tuberculosis on T-cell activation and proliferation in patients with and without HIV co-infection. Journal of Infection. 51(5). 408–412. 7 indexed citations

15.

Villacian, Jorge, et al.. (2004). Prevalence of and Risk Factors for Nasal Colonization With Staphylococcus aureus Among Human Immunodeficiency Virus-Positive Outpatients in Singapore. Infection Control and Hospital Epidemiology. 25(5). 438–440. 32 indexed citations

16.

Hsu, Li Yang, Justin A. Green, Brenda Ang, et al.. (2003). Severe Acute Respiratory Syndrome (SARS) in Singapore: Clinical Features of Index Patient and Initial Contacts. Emerging infectious diseases. 9(6). 713–717. 218 indexed citations

17.

Singh, Kamaljit, Li Yang Hsu, Jorge Villacian, et al.. (2003). Severe Acute Respiratory Syndrome: Lessons from Singapore. Emerging infectious diseases. 9(10). 1294–1298. 22 indexed citations

18.

Chadwick, David, Jeffrey Pido-Lopez, António Pires, et al.. (2003). A pilot study of the safety and efficacy of thymosinα1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy. Clinical & Experimental Immunology. 134(3). 477–481. 29 indexed citations

19.

Villacian, Jorge & Carlos V. Payá. (1999). Prevention of infections in solid organ transplant recipients. Transplant Infectious Disease. 1(1). 50–64. 43 indexed citations

20.

Dockrell, David H., Andrew D. Badley, Jorge Villacian, et al.. (1998). The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection.. Journal of Clinical Investigation. 101(11). 2394–2405. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact